Clay B. Siegall

2008

In 2008, Clay B. Siegall earned a total compensation of $2.3M as President and CEO at Seattle Genetics, a 35% decrease compared to previous year.

Compensation breakdown

Bonus$1,500
Non-Equity Incentive Plan$359,375
Option Awards$1,379,242
Salary$567,958
Other$7,440
Total$2,315,515

Siegall received $1.4M in option awards, accounting for 60% of the total pay in 2008.

Siegall also received $1.5K in bonus, $359.4K in non-equity incentive plan, $568K in salary and $7.4K in other compensation.

Rankings

In 2008, Clay B. Siegall's compensation ranked 2,091st out of 9,135 executives tracked by ExecPay. In other words, Siegall earned more than 77.1% of executives.

ClassificationRankingPercentile
All
2,091
out of 9,135
77th
Division
Manufacturing
760
out of 3,436
78th
Major group
Chemicals And Allied Products
138
out of 815
83rd
Industry group
Drugs
82
out of 597
86th
Industry
Biological Products, Except Diagnostic Substances
15
out of 118
87th
Source: SEC filing on April 8, 2011.

Siegall's colleagues

We found four more compensation records of executives who worked with Clay B. Siegall at Seattle Genetics in 2008.

2008

Eric Dobmeier

Seattle Genetics

Chief Business Officer

2008

Thomas Reynolds

Seattle Genetics

Chief Medical Officer

2008

Morris Rosenberg

Seattle Genetics

EVP, Process Sciences

2008

Todd Simpson

Seattle Genetics

Chief Financial Officer

News

In-depth

You may also like